Current data suggest that the rate of breastfeeding in the United States is far below the recommendation of the American Academy of Pediatrics that all infants be exclusively breastfed for the first 6 ...
KETABET™, a patented combination formulation of FDA-approved ketamine and betaine anhydrous, has been shown in research to enhance the antidepressant effect while having the potential to reduce the ...
April 6, 2007 — Results of 2 randomized studies assessing a fixed-dose tablet combining sumatriptan and naproxen ( Trexima, Pozen Inc/GlaxoSmithKline) suggest that the combination offers more ...
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide. (Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a ...
PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the expansion of its formulation capabilities to now include colostrum plus probiotic ...
Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...
It is estimated that approximately half of patients take their medications improperly. In the United States alone, adherence problems result in estimated costs of up to $100 billion annually. This is ...
Trial Did Not Meet Primary Endpoint Believed to be the Result of BOTOX Not Effectively Permeating the Urothelium RTGel Delivered Treatment to the Bladder as Expected with Dwell Time of Up to 10 Hours ...
Acrux (ASX: ACR) -- The Australian drug delivery company, today announced positive results from its Phase 1 clinical studies using two unique contraceptive skin sprays, each containing a progestin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results